416 research outputs found
Loss of redundant gene expression after polyploidization in plants
Based on chromosomal location data of genes encoding 28 biochemical systems in allohexaploid wheat,Triticum aestivum L. (genomes AABBDD), it is concluded that the proportions of systems controlled by triplicate, duplicate, and single loci are 57%, 25%, and 18% respectively
Evolutionary q-Gaussian radial basis function neural networks for multiclassification
This paper proposes a radial basis function neural network (RBFNN), called the q-Gaussian RBFNN, that reproduces different radial basis functions (RBFs) by means of a real parameter q. The architecture, weights and node topology are learnt through a hybrid algorithm (HA). In order to test the overall performance, an experimental study with sixteen data sets taken from the UCI repository is presented. The q-Gaussian RBFNN was compared to RBFNNs with Gaussian, Cauchy and inverse multiquadratic RBFs in the hidden layer and to other probabilistic classifiers, including different RBFNN design methods, support vector machines (SVMs), a sparse classifier (sparse multinomial logistic regression, SMLR) and a non-sparse classifier (regularized multinomial logistic regression, RMLR). The results show that the q-Gaussian model can be considered very competitive with the other classification methods. © 2011 Elsevier Ltd
Combination of KIR2DS4 and FcÎłRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Cetuximab; Metastatic colorectal cancer; KIR genesCetuximab; Cà ncer colorectal amb metà stasi; Gens KIRCetuximab; Cáncer colorrectal con metástasis; Genes KIRCetuximab is a standard-of-care treatment for RAS wild-type metastatic colorectal cancer (mCRC) but not for those harbor a KRAS mutation since MAPK pathway is constitutively activated. Nevertheless, cetuximab also exerts its effect by its immunomodulatory activity despite the presence of RAS mutation. The aim of this study was to determine the impact of polymorphism FcγRIIIa V158F and killer immunoglobulin-like receptor (KIR) genes on the outcome of mCRC patients with KRAS mutations treated with cetuximab. This multicenter Phase II clinical trial included 70 mCRC patients with KRAS mutated. We found KIR2DS4 gene was significantly associated with OS (HR 2.27; 95% CI, 1.08-4.77; P = 0.03). In non-functional receptor homozygotes the median OS was 2.6 months longer than in carriers of one copy of full receptor. Multivariate analysis confirmed KIR2DS4 as a favorable prognostic marker for OS (HR 6.71) in mCRC patients with KRAS mutation treated with cetuximab. These data support the potential therapeutic of cetuximab in KRAS mutated mCRC carrying non-functional receptor KIR2DS4 since these patients significantly prolong their OS even after heavily treatment. KIR2DS4 typing could be used as predictive marker for identifying RAS mutated patients that could benefit from combination approaches of anti-EGFR monoclonal antibodies and other immunotherapies to overcome the resistance mediated by mutation in RAS
Homoeologous chromosomal location of the genes encoding thionins in wheat and rye
Thionins are high sulphur basic polypeptides present in the endosperm of Gramineae. In wheat there are three thionins encoded by genes located in the long arms of chromosomes 1A, 1B and 1D. Rye has one thionin encoded by a gene which has been assigned to chromosome 1R after analysis of the Imperial-Chinese Spring rye-wheat disomic addition lines. Commercial varieties and experimental stocks with a 1B/1R substitution carry the thionin from rye ( R) instead of the B thionin from wheat. The R thionin gene is not located in the large chromosomal segment representing most of the short arm of chromosome 1R
Metabolic flexibility as a major predictor of spatial distribution in microbial communities
A better understand the ecology of microbes and their role in the global ecosystem could be achieved if traditional ecological theories can be applied to microbes. In ecology organisms are defined as specialists or generalists according to the breadth of their niche. Spatial distribution is often used as a proxy measure of niche breadth; generalists have broad niches and a wide spatial distribution and specialists a narrow niche and spatial distribution. Previous studies suggest that microbial distribution patterns are contrary to this idea; a microbial generalist genus (Desulfobulbus) has a limited spatial distribution while a specialist genus (Methanosaeta) has a cosmopolitan distribution. Therefore, we hypothesise that this counter-intuitive distribution within generalist and specialist microbial genera is a common microbial characteristic. Using molecular fingerprinting the distribution of four microbial genera, two generalists, Desulfobulbus and the methanogenic archaea Methanosarcina, and two specialists, Methanosaeta and the sulfate-reducing bacteria Desulfobacter were analysed in sediment samples from along a UK estuary. Detected genotypes of both generalist genera showed a distinct spatial distribution, significantly correlated with geographic distance between sites. Genotypes of both specialist genera showed no significant differential spatial distribution. These data support the hypothesis that the spatial distribution of specialist and generalist microbes does not match that seen with specialist and generalist large organisms. It may be that generalist microbes, while having a wider potential niche, are constrained, possibly by intrageneric competition, to exploit only a small part of that potential niche while specialists, with far fewer constraints to their niche, are more capable of filling their potential niche more effectively, perhaps by avoiding intrageneric competition. We suggest that these counter-intuitive distribution patterns may be a common feature of microbes in general and represent a distinct microbial principle in ecology, which is a real challenge if we are to develop a truly inclusive ecology
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014
Influencia del cultivo de Lupinus luteus L. en la densidad de inĂłculo de Phytophthora cinnamomi en suelos de dehesa
Phytophthora cinnamomi es un patĂłgeno que causa podredumbre radical en el arbolado de la dehesa y tambiĂ©n en Lupinus luteus, cultivo frecuente en dehesas de AndalucĂa occidental. En dehesas que mostraban distintas situaciones en cuanto a decaimiento del arbolado y severidad de la enfermedad en el altramuz, el aislamiento y conteo de colonias de P. cinnamomi a partir de muestras de suelo ha mostrado la capacidad del cultivo herbáceo para mantener o incrementar la densidad de inĂłculo y asĂ potenciar la infecciĂłn de las encinas. Los resultados obtenidos desaconsejan el cultivo de esta leguminosa en dehesas con presencia del patĂłgeno en el suelo, tanto si el arbolado sufre la enfermedad radical o no
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
In this update of the consensus of the Spanish Society of Medical Oncology (Sociedad Española de OncologĂa MĂ©dica SEOM) and the Spanish Society of Pathology (Sociedad Española de AnatomĂa PatolĂłgica SEAP), advances in the analysis of biomarkers in advanced colorectal cancer (CRC) as well as susceptibility markers of hereditary CRC and molecular biomarkers of localized CRC are reviewed. Recently published information on the essential determination of KRAS, NRAS and BRAF mutations and the convenience of determining the amplifcation of human epidermal growth factor receptor 2 (HER2), the expression of proteins in the DNA repair pathway and the study of NTRK fusions are also evaluated. From the pathological point of view, the importance of analysing the tumour budding and poorly diferentiated clusters, and its prognostic value in CRC is reviewed, as well as the impact of molecular lymph node analysis on lymph node staging in CRC. The incorporation of pan-genomic technologies, such as next-generation sequencing (NGS) and liquid biopsy in the clinical management of patients with CRC is also outlined. All these aspects are developed in this guide, which, like the previous one, will remain open to any necessary revision in the future
- …